Top
image credit: Adobe Stock

Research: Proscia AI Predicts Diagnostic Agreement for Melanoma

November 2, 2022

Proscia is a software company that is accelerating pathology’s digital transformation to change the way we understand diseases like cancer. Its Concentriq digital pathology platform and powerful AI applications are advancing the 150-year-old standard of research and diagnosis towards a data-driven discipline, unlocking new insights that accelerate discovery, improve patient outcomes, and fulfil the promise of precision care.

Read More on HitConsultant